바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.78 No.4
Citation Share

A Case of Severe Pseudomembranous Tracheobronchitis Complicated by Co-infection of Influenza A (H1N1) and Staphylococcus aureus in an Immunocompetent Patient

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2015, v.78 no.4, pp.366-370








& (2015). A Case of Severe Pseudomembranous Tracheobronchitis Complicated by Co-infection of Influenza A (H1N1) and Staphylococcus aureus in an Immunocompetent Patient. Tuberculosis & Respiratory Diseases, 78(4), 366-370.
  • Downloaded
  • Viewed
PDF Download

Abstract

Although influenza A (H1N1) virus leads to self-limiting illness, co-infection with bacteria may result in cases of severe respiratory failure due to inflammation and necrosis of intra-airway, as pseudomembranous tracheobronchitis. Pseudomembranous tracheobronchitis is usually developed in immunocompromised patients, but it can also occur in immunocompetent patients on a very rare basis. We report a case of pseudomembranous tracheobronchitis complicated by co-infection of inflenaza A and Staphylococcus aureus, causing acute respiratory failure in immunocompetent patients.

keywords
Influenza, Human, Staphylococcus aureus

Reference

1.

1. World Headth Organization. World now at the start of 2009 influenza pandemic [Internet]. Geneva: World Health Organization; 2009 [cited 2015 Mar 1]. Available from: http://who. int/mediacentre/news/statements/2009/h1n1_pandemic_ phase6_20090611/en/index.html.

2.

2. Korea Centers for Disease Control and Prevention. H1N1 influenza A (H1N1) press release [Internet]. Seoul: Korea Centers for Disease Control and Prevention; 2009 [cited 2015 Mar 1]. Available from: http://www.cdc.go.kr/.

3.

3. McCullers JA. (2006), Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev, 19,571-82.

4.

4. Brundage JF. (2006), Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis, 6,303-12.

5.

5. Smith CB., Kanner RE., Golden CA., Klauber MR., Renzetti AD Jr. (1980), Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis, 141,271-80.

6.

6. Talwar A., Patel N., Omonuwa K., Lisker G. (2008), Postintubation obstructive pseudomembrane. J Bronchol, 15,110-2.

7.

7. Nam KH., Hong JS., Hong MY., Lim JM., Kim MH., Jung BH. (2011), A case of pseudomembranous tracheobronchitis complicated by coinfection of 2009 pandemic influenza A/H1N1 and Staphylococcus aureus . Infect Chemother, 43,425-8.

8.

8. Jain S., Kamimoto L., Bramley AM., Schmitz AM., Benoit SR., Louie J. (2009), Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med, 361, 1935-44.

9.

9. Chertow DS., Memoli MJ. (2013), Bacterial coinfection in influenza: a grand rounds review. JAMA, 309,275-82.

10.

10. Tashiro M., Ciborowski P., Klenk HD., Pulverer G., Rott R. (1987), Role of Staphylococcus protease in the development of influenza pneumonia. Nature, 325,536-7.

11.

11. Namba Y., Mihara N., Tanaka M. (1997), Fulminant tracheobronchitis caused by methicillin-resistant Staphylococcus aureus (MRSA). Nihon Kyobu Shikkan Gakkai Zasshi, 35,969- 73.

12.

12. Herrmann RE., Ogura GI., Johnson ES., Toll HW Jr., White WC. (1958), Respiratory deaths associated with Asian influenza epidemic: report of twenty-three cases. J Am Med Assoc, 166,467- 71.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy